A novel virus-like particle vaccine presenting HER-2 extracellular domain elicits strong immune responses against mammary carcinoma

被引:1
|
作者
Palladini, Arianna [1 ]
Thrane, Susan [2 ]
Janitzek, Christoph M. [2 ]
Pihl, Jessica [2 ]
Clemmensen, Stine B. [2 ]
de Jongh, Wilhelm A. [3 ]
Clausen, Thomas M. [2 ]
Nicoletti, Giordano [4 ]
Landuzzi, Lorena [4 ]
Penichet, Manuel L. [5 ]
Balboni, Tania [1 ]
Ianzano, Marianna L. [1 ]
Giusti, Veronica [1 ]
Theander, Thor H. [2 ]
Nielsen, Morten A. [2 ]
Salanti, Ali [2 ]
Lollini, Pier-Luigi [1 ]
Nanni, Patrizia [1 ]
Sander, Adam F. [2 ]
机构
[1] Univ Bologna, Bologna, Italy
[2] Univ Copenhagen, Copenhagen, Denmark
[3] Expres2ion Biotechnol, Horsholm, Denmark
[4] Rizzoli Orthopaed Inst, Bologna, Italy
[5] Univ Calif Los Angeles, Los Angeles, CA USA
基金
欧洲研究理事会;
关键词
D O I
10.1158/1538-7445.AM2018-716
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
716
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Development of a Virus-Like Particle-Based Anti-HER2 Breast Cancer Vaccine
    Hu, He
    Steinmetz, Nicole F.
    CANCERS, 2021, 13 (12)
  • [22] Insect Cell-Based Quadrivalent Seasonal Influenza Virus-like Particles Vaccine Elicits Potent Immune Responses in Mice
    Badruzzaman, A. T. M.
    Cheng, Yu-Chieh
    Sung, Wang-Chou
    Lee, Min-Shi
    VACCINES, 2024, 12 (06)
  • [23] A self-binding immune complex vaccine elicits strong neutralizing responses against herpes simplex virus in mice
    Diamos, Andrew G.
    Pardhe, Mary D.
    Bergeman, Melissa H.
    Kamzina, Aigerim S.
    DiPalma, Michelle P.
    Aman, Sara
    Chaves, Artemio
    Lowe, Kenneth
    Kilbourne, Jacquelyn
    Hogue, Ian B.
    Mason, Hugh S.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [24] Danger signals and nonself entity of tumor antigen are both required for eliciting effective immune responses against HER-2/neu positive mammary carcinoma: implications for vaccine design
    Kmieciak, Maciej
    Morales, Johanna K.
    Morales, Joshua
    Bolesta, Elizabeth
    Grimes, Margaret
    Manjili, Masoud H.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (09) : 1391 - 1398
  • [25] Danger signals and nonself entity of tumor antigen are both required for eliciting effective immune responses against HER-2/neu positive mammary carcinoma: implications for vaccine design
    Maciej Kmieciak
    Johanna K. Morales
    Joshua Morales
    Elizabeth Bolesta
    Margaret Grimes
    Masoud H. Manjili
    Cancer Immunology, Immunotherapy, 2008, 57 : 1391 - 1398
  • [26] Immunogenicity evaluation of a novel virus-like particle vaccine candidate against SARS-CoV-2 in BALB/c
    Bahramali, Golnaz
    Mashhadi Abolghasem Shirazi, Maryam
    Hannan, Mina
    Aghasadeghi, Mohammad Reza
    Khosravy, Mohammad Sadeq
    Arjmand, Sina
    Sadat, Seyed Mehdi
    PATHOGENS AND DISEASE, 2023, 81
  • [27] Protective effects of a novel chimeric virus-like particle vaccine against virulent NDV and IBDV challenge
    Li, Jindou
    Ding, Jiaxin
    Chen, Kainan
    Xu, Xiaohong
    Shao, Yanan
    Zhang, Di
    Yu, Xibing
    Guo, Chunhong
    Qian, Jing
    Ding, Zhuang
    VACCINE, 2024, 42 (02) : 332 - 338
  • [28] Virus-like particle display of HER2 induces potent anti-cancer responses
    Palladini, Arianna
    Thrane, Susan
    Janitzek, Christoph M.
    Pihl, Jessica
    Clemmensen, Stine B.
    de Jongh, Willem Adriaan
    Clausen, Thomas M.
    Nicoletti, Giordano
    Landuzzi, Lorena
    Penichet, Manuel L.
    Balboni, Tania
    Ianzano, Marianna L.
    Giusti, Veronica
    Theander, Thor G.
    Nielsen, Morten A.
    Salanti, Ali
    Lollini, Pier-Luigi
    Nanni, Patrizia
    Sander, Adam F.
    ONCOIMMUNOLOGY, 2018, 7 (03):
  • [29] Protective immune responses against foot-and-mouth disease virus by vaccination with a DNA vaccine expressing virus-like particles
    Jin, Huali
    Xiao, Wang
    Xiao, Chong
    Yu, Yang
    Kang, Youmin
    Du, Xiaogang
    Wei, Xuefeng
    Wang, Bin
    VIRAL IMMUNOLOGY, 2007, 20 (03) : 429 - 440
  • [30] Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine
    Nardelli-Haefliger, D
    Lurati, F
    Wirthner, D
    Spertini, F
    Schiller, JT
    Lowy, DR
    Ponci, F
    De Grandi, P
    VACCINE, 2005, 23 (28) : 3634 - 3641